Endocrinology Advisor
@endocrinologyadv.bsky.social
Endocrinology Advisor provides healthcare professionals with comprehensive information and clinical news on the management of endocrine conditions.
A #ReproductiveEndocrinologist was sued for #MedicalMalpractice after a patient received a diagnosis of #OvarianCancer after undergoing #FertilityTreatment.
Reproductive Endocrinologist Found Liable for Failing to Diagnose Ovarian Cancer
A reproductive endocrinologist was found liable in a medical malpractice lawsuit after failing to diagnose a patient with ovarian cancer.
www.endocrinologyadvisor.com
July 25, 2025 at 4:57 PM
A #ReproductiveEndocrinologist was sued for #MedicalMalpractice after a patient received a diagnosis of #OvarianCancer after undergoing #FertilityTreatment.
#CentralPrecociousPuberty elevated risk for #MentalDisorders as early as 1 year before diagnosis and up to 8 years after diagnosis.
@unidue.bsky.social @ruhr-uni-bochum.de
@unidue.bsky.social @ruhr-uni-bochum.de
Central Precocious Puberty Elevates Psychiatric Disorder Risk
Central precocious puberty was associated with elevated risk for psychiatric disorders including depression, ADHD, and anxiety.
www.endocrinologyadvisor.com
July 25, 2025 at 4:04 PM
#CentralPrecociousPuberty elevated risk for #MentalDisorders as early as 1 year before diagnosis and up to 8 years after diagnosis.
@unidue.bsky.social @ruhr-uni-bochum.de
@unidue.bsky.social @ruhr-uni-bochum.de
#Amputation risk was significantly reduced among patients with #T2D who used #GLP1RAs compared with #SGLT2is.
@dgarmstrong.bsky.social @keck.usc.edu @uscsurgery.bsky.social
@dgarmstrong.bsky.social @keck.usc.edu @uscsurgery.bsky.social
GLP-1RAs Better Reduce Amputation Risk Than SGLT2is in T2D
GLP-1RAs were associated with significantly reduced risk for amputations relative to SGLT2is among patients with type 2 diabetes.
www.endocrinologyadvisor.com
July 25, 2025 at 3:18 PM
#Amputation risk was significantly reduced among patients with #T2D who used #GLP1RAs compared with #SGLT2is.
@dgarmstrong.bsky.social @keck.usc.edu @uscsurgery.bsky.social
@dgarmstrong.bsky.social @keck.usc.edu @uscsurgery.bsky.social
Still catching up on research from #ENDO2025? Find all of Endocrinology Advisor's coverage from this month's conference below ⬇️ @endocrinesociety.bsky.social
Endocrine Society Archives
Presenting research from ENDO, the annual meeting of the Endocrine Society.
www.endocrinologyadvisor.com
July 24, 2025 at 1:49 PM
Still catching up on research from #ENDO2025? Find all of Endocrinology Advisor's coverage from this month's conference below ⬇️ @endocrinesociety.bsky.social
Relative to #GLP1RA and #DPP4i use, #SGLT2i use was associated with an increased risk for #erythrocytosis but not an increased risk for #thrombosis in #T2D.
SGLT2 Inhibitor Use Linked to Increased Risk for Erythrocytosis, Not Thrombosis
SGLT2 inhibitor use was associated with an increased risk for erythrocytosis but not thrombosis among patients with type 2 diabetes.
www.endocrinologyadvisor.com
July 23, 2025 at 5:04 PM
Relative to #GLP1RA and #DPP4i use, #SGLT2i use was associated with an increased risk for #erythrocytosis but not an increased risk for #thrombosis in #T2D.
Changes in #BoneMineralDensity were mediated by changes in E2 and testosterone among women and men, respectively, with #T2D undergoing weight loss.
@erinmichos.bsky.social @johnshopkinssph.bsky.social @jhu.edu @imperialcollegeldn.bsky.social @uthsc.bsky.social
@erinmichos.bsky.social @johnshopkinssph.bsky.social @jhu.edu @imperialcollegeldn.bsky.social @uthsc.bsky.social
Weight Loss-Induced Sex Hormone Changes May Affect BMD Loss in T2D
Weight loss-induced sex hormone changes had a mediating effect on bone mineral density loss among patients with type 2 diabetes.
www.endocrinologyadvisor.com
July 23, 2025 at 2:02 PM
Changes in #BoneMineralDensity were mediated by changes in E2 and testosterone among women and men, respectively, with #T2D undergoing weight loss.
@erinmichos.bsky.social @johnshopkinssph.bsky.social @jhu.edu @imperialcollegeldn.bsky.social @uthsc.bsky.social
@erinmichos.bsky.social @johnshopkinssph.bsky.social @jhu.edu @imperialcollegeldn.bsky.social @uthsc.bsky.social
Pre-visit patient activation enhanced the positive effect of PCP academic detailing on diabetes #deprescribing rates among older adults with #T2D.
@kaiser-permanente.bsky.social @yaleschoolofmed.bsky.social
@kaiser-permanente.bsky.social @yaleschoolofmed.bsky.social
Academic Detailing Plus Pre-Visit Handout Improves Diabetes Deprescribing
Academic detailing plus pre-visit patient activation was associated with sustained diabetes deprescribing rates at 12 months in older adults with T2D.
www.endocrinologyadvisor.com
July 22, 2025 at 5:07 PM
Pre-visit patient activation enhanced the positive effect of PCP academic detailing on diabetes #deprescribing rates among older adults with #T2D.
@kaiser-permanente.bsky.social @yaleschoolofmed.bsky.social
@kaiser-permanente.bsky.social @yaleschoolofmed.bsky.social
Reduced heavy menstrual bleeding was sustained with #linzagolix therapy, regardless of adjunct hormonal add-back therapy, at 1 year among patients with #UterineFibroids.
@yaleschoolofmed.bsky.social @ox.ac.uk @goetheuni.bsky.social @ub.edu
@yaleschoolofmed.bsky.social @ox.ac.uk @goetheuni.bsky.social @ub.edu
Linzagolix Sustains Reduced Menstrual Bleeding in Uterine Fibroids at 1 Year
Linzagolix therapy was associated with significantly reduced heavy menstrual bleeding by week 52 among patients with uterine fibroids.
www.endocrinologyadvisor.com
July 22, 2025 at 2:19 PM
Reduced heavy menstrual bleeding was sustained with #linzagolix therapy, regardless of adjunct hormonal add-back therapy, at 1 year among patients with #UterineFibroids.
@yaleschoolofmed.bsky.social @ox.ac.uk @goetheuni.bsky.social @ub.edu
@yaleschoolofmed.bsky.social @ox.ac.uk @goetheuni.bsky.social @ub.edu
#Gestational #GlucoseIntolerance was associated with increased #obesity risk, especially among children aged 11 to 18 years.
@cepowemd.bsky.social @mgbresearch.bsky.social @harvardmed.bsky.social
@cepowemd.bsky.social @mgbresearch.bsky.social @harvardmed.bsky.social
Gestational Glucose Intolerance, Diabetes Influences Childhood Obesity
Gestational glucose intolerance was associated with increased risk for obesity and overweight, especially among children aged 11 to 18 years.
www.endocrinologyadvisor.com
July 18, 2025 at 5:06 PM
#Gestational #GlucoseIntolerance was associated with increased #obesity risk, especially among children aged 11 to 18 years.
@cepowemd.bsky.social @mgbresearch.bsky.social @harvardmed.bsky.social
@cepowemd.bsky.social @mgbresearch.bsky.social @harvardmed.bsky.social
From #ENDO2025: There are significant reductions in patient-reported symptom severity among patients with #acromegaly treated with paltusotine.
@endocrinesociety.bsky.social
@endocrinesociety.bsky.social
Paltusotine Improves Patient-Reported Acromegaly Symptoms
Paltusotine treatment is associated with significant reductions in patient-reported symptom severity among patients with acromegaly.
www.endocrinologyadvisor.com
July 17, 2025 at 7:43 PM
From #ENDO2025: There are significant reductions in patient-reported symptom severity among patients with #acromegaly treated with paltusotine.
@endocrinesociety.bsky.social
@endocrinesociety.bsky.social
From #ENDO2025: Veligrotug vs placebo was associated with significant improvements in #proptosis, #diplopia, and clinical activity score in active #ThyroidEyeDisease.
@endocrinesociety.bsky.social @uwmedicine.bsky.social @bcmhouston.bsky.social @keck.usc.edu @stanfordmedicine.bsky.social
@endocrinesociety.bsky.social @uwmedicine.bsky.social @bcmhouston.bsky.social @keck.usc.edu @stanfordmedicine.bsky.social
Veligrotug Safe, Efficacious for Active TED
Veligrotug demonstrated significant improvements in proptosis, diplopia, and clinical activity score among patients with active thyroid eye disease.
www.endocrinologyadvisor.com
July 17, 2025 at 5:33 PM
From #ENDO2025: Veligrotug vs placebo was associated with significant improvements in #proptosis, #diplopia, and clinical activity score in active #ThyroidEyeDisease.
@endocrinesociety.bsky.social @uwmedicine.bsky.social @bcmhouston.bsky.social @keck.usc.edu @stanfordmedicine.bsky.social
@endocrinesociety.bsky.social @uwmedicine.bsky.social @bcmhouston.bsky.social @keck.usc.edu @stanfordmedicine.bsky.social
From #ENDO2025: Among #tirzepatide users, women experienced greater reductions in total #cholesterol, LDL cholesterol, and weight than men.
@endocrinesociety.bsky.social @mayoclinic.org
@endocrinesociety.bsky.social @mayoclinic.org
Tirzepatide Cardiometabolic Benefits Greater in Women vs Men
Tirzepatide yielded greater cardiometabolic benefits, especially in total cholesterol, LDL cholesterol, and weight loss, among women than men.
www.endocrinologyadvisor.com
July 17, 2025 at 3:37 PM
From #ENDO2025: Among #tirzepatide users, women experienced greater reductions in total #cholesterol, LDL cholesterol, and weight than men.
@endocrinesociety.bsky.social @mayoclinic.org
@endocrinesociety.bsky.social @mayoclinic.org
From #ENDO2025: Diazoxide choline extended-release tablets for #hyperphagia demonstrated favorable #glycemic safety across 4 years among patients with #PraderWilliSyndrome
@endocrinesociety.bsky.social @nationwidekids.bsky.social @seattlechildrens.org
@endocrinesociety.bsky.social @nationwidekids.bsky.social @seattlechildrens.org
Diazoxide Choline Extended-Release Safe for Hyperphagia in Prader-Willi Syndrome
Diazoxide choline extended-release tablets demonstrated favorable safety profile across 4 years among patients with Prader-Willi Syndrome.
www.endocrinologyadvisor.com
July 17, 2025 at 1:38 PM
From #ENDO2025: Diazoxide choline extended-release tablets for #hyperphagia demonstrated favorable #glycemic safety across 4 years among patients with #PraderWilliSyndrome
@endocrinesociety.bsky.social @nationwidekids.bsky.social @seattlechildrens.org
@endocrinesociety.bsky.social @nationwidekids.bsky.social @seattlechildrens.org
From #ENDO2025: #BariatricSurgery #WeightLoss outcomes were comparable between adolescent girls with and without #PCOS.
@endocrinesociety.bsky.social @nufeinbergmed.bsky.social @umnsph.bsky.social @tamu.bsky.social @cincychildrens.bsky.social @luriechildrens.bsky.social
@endocrinesociety.bsky.social @nufeinbergmed.bsky.social @umnsph.bsky.social @tamu.bsky.social @cincychildrens.bsky.social @luriechildrens.bsky.social
Adolescents With PCOS Show Modest Weight Loss After Bariatric Surgery
Adolescents with PCOS demonstrated comparable weight loss to their reproductively normal peers after undergoing bariatric surgery.
www.endocrinologyadvisor.com
July 16, 2025 at 6:50 PM
From #ENDO2025: #BariatricSurgery #WeightLoss outcomes were comparable between adolescent girls with and without #PCOS.
@endocrinesociety.bsky.social @nufeinbergmed.bsky.social @umnsph.bsky.social @tamu.bsky.social @cincychildrens.bsky.social @luriechildrens.bsky.social
@endocrinesociety.bsky.social @nufeinbergmed.bsky.social @umnsph.bsky.social @tamu.bsky.social @cincychildrens.bsky.social @luriechildrens.bsky.social
From #ENDO2025: #ThyroidCancer attributable to high #BMI increased from 1990 to 2021, especially among older adults and men.
@endocrinesociety.bsky.social
@endocrinesociety.bsky.social
Thyroid Cancer Burden Due to High BMI on the Rise in US
Thyroid cancer burden attributable to high BMI was increasing between 1990 and 2021 in the US, especially among men and older adults.
www.endocrinologyadvisor.com
July 16, 2025 at 5:10 PM
From #ENDO2025: #ThyroidCancer attributable to high #BMI increased from 1990 to 2021, especially among older adults and men.
@endocrinesociety.bsky.social
@endocrinesociety.bsky.social
From #ENDO2025: Presence of #adrenal #adenoma was associated with lower #WeightLoss among patients with #obesity using #GLP1 or GIP/GLP-1 receptor agonists.
@endocrinesociety.bsky.social
@endocrinesociety.bsky.social
Adrenal Adenomas May Attenuate Weight Loss With Incretin-Based Therapy
Adrenal adenomas were associated with attenuated weight loss among patients with obesity or overweight using GLP-1 or GIP/GLP-1 RAs.
www.endocrinologyadvisor.com
July 16, 2025 at 2:51 PM
From #ENDO2025: Presence of #adrenal #adenoma was associated with lower #WeightLoss among patients with #obesity using #GLP1 or GIP/GLP-1 receptor agonists.
@endocrinesociety.bsky.social
@endocrinesociety.bsky.social
From #ENDO2025: #Tirzepatide was superior to #semaglutide in achieving standard and intensive #cardiometabolic targets among patients with #T2D.
@endocrinesociety.bsky.social
@endocrinesociety.bsky.social
Tirzepatide Superior to Semaglutide in T2D Therapy Targets
Tirzepatide was superior to semaglutide in achieving standard and intensive cardiometabolic targets among patients with type 2 diabetes.
www.endocrinologyadvisor.com
July 16, 2025 at 1:19 PM
From #ENDO2025: #Tirzepatide was superior to #semaglutide in achieving standard and intensive #cardiometabolic targets among patients with #T2D.
@endocrinesociety.bsky.social
@endocrinesociety.bsky.social
From #ENDO2025: Glucopilot dynamic dosing algorithm improved #glycemia management, especially among patients with #diabetic #ketoacidosis, #sepsis, and #steroid use.
@endocrinesociety.bsky.social @jhu.edu
@endocrinesociety.bsky.social @jhu.edu
Glucopilot Dynamic Dosing Algorithm for IV Insulin Therapy Improves Hypoglycemia
Glucopilot dynamic dosing algorithm was associated with improved glycemic control especially among subgroups with hard-to-manage glycemia.
www.endocrinologyadvisor.com
July 15, 2025 at 8:35 PM
From #ENDO2025: Glucopilot dynamic dosing algorithm improved #glycemia management, especially among patients with #diabetic #ketoacidosis, #sepsis, and #steroid use.
@endocrinesociety.bsky.social @jhu.edu
@endocrinesociety.bsky.social @jhu.edu
From #ENDO2025: In pediatric #CongenitalAdrenalHyperplasia, crinecerfont is associated with sustained reductions in androstenedione levels and #glucocorticoid doses at 1 year.
@endocrinesociety.bsky.social
@endocrinesociety.bsky.social
Crinecerfont Maintains A4, GC Reductions in Pediatric CAH at 1 Year
Crinecerfont is associated with sustained reductions in androstenedione and GC doses at 1 year in congenital adrenal hyperplasia.
www.endocrinologyadvisor.com
July 15, 2025 at 7:22 PM
From #ENDO2025: In pediatric #CongenitalAdrenalHyperplasia, crinecerfont is associated with sustained reductions in androstenedione levels and #glucocorticoid doses at 1 year.
@endocrinesociety.bsky.social
@endocrinesociety.bsky.social
From #ENDO2025: Women with #thrombotic disease and comorbid #PCOS had higher rates of #vascular events and presented at a younger age than those with thrombotic disease and no PCOS.
@endocrinesociety.bsky.social
@endocrinesociety.bsky.social
PCOS May Increase Vascular Event Risk in Thrombotic Disease
PCOS was associated with an increased risk for vascular events including stroke among women with thrombotic disease, and a lower mean age.
www.endocrinologyadvisor.com
July 15, 2025 at 5:12 PM
From #ENDO2025: Women with #thrombotic disease and comorbid #PCOS had higher rates of #vascular events and presented at a younger age than those with thrombotic disease and no PCOS.
@endocrinesociety.bsky.social
@endocrinesociety.bsky.social
From #ENDO2025: Although the addition of #metformin offered little benefit, combined #OralContraceptive pills were associated with improved #obesity outcomes in hyperandrogenic #PCOS.
@endocrinesociety.bsky.social @upenn.edu
@endocrinesociety.bsky.social @upenn.edu
COCPs Improve Obesity Outcomes in Hyperandrogenic PCOS
COCPs were associated with improved obesity outcomes among patients with hyperandrogenic PCOS, but metformin added little benefit.
www.endocrinologyadvisor.com
July 15, 2025 at 2:56 PM
From #ENDO2025: Although the addition of #metformin offered little benefit, combined #OralContraceptive pills were associated with improved #obesity outcomes in hyperandrogenic #PCOS.
@endocrinesociety.bsky.social @upenn.edu
@endocrinesociety.bsky.social @upenn.edu
From #ENDO2025: #HormoneTherapy plus #tirzepatide was associated with greater #WeightLoss than tirzepatide among #postmenopausal women.
@endocrinesociety.bsky.social @mayoclinic.org
@endocrinesociety.bsky.social @mayoclinic.org
Hormone Therapy Plus Tirzepatide Enhances Postmenopausal Weight Loss
Hormone therapy as an adjunctive to tirzepatide was associated with greater weight loss than tirzepatide alone among postmenopausal women.
www.endocrinologyadvisor.com
July 15, 2025 at 1:06 PM
From #ENDO2025: #HormoneTherapy plus #tirzepatide was associated with greater #WeightLoss than tirzepatide among #postmenopausal women.
@endocrinesociety.bsky.social @mayoclinic.org
@endocrinesociety.bsky.social @mayoclinic.org
From #ENDO2025: #Osteoporosis treatment following fragility #Fracture was associated with significantly reduced #hospitalization and mortality risks among patients aged 80 years and older.
@endocrinesociety.bsky.social @clevelandclinic.bsky.social @upstatemedical.bsky.social
@endocrinesociety.bsky.social @clevelandclinic.bsky.social @upstatemedical.bsky.social
Osteoporosis Treatment After Fragility Fracture Lowers Mortality Risk
Osteoporosis treatment was associated with reduced hospitalization and mortality risks following fragility fracture after 80 years of age.
www.endocrinologyadvisor.com
July 14, 2025 at 7:54 PM
From #ENDO2025: #Osteoporosis treatment following fragility #Fracture was associated with significantly reduced #hospitalization and mortality risks among patients aged 80 years and older.
@endocrinesociety.bsky.social @clevelandclinic.bsky.social @upstatemedical.bsky.social
@endocrinesociety.bsky.social @clevelandclinic.bsky.social @upstatemedical.bsky.social
From #ENDO2025: #Setmelanotide was associated with significant #WeightReduction among adult and pediatric patients with acquired #HypothalamicObesity.
@endocrinesociety.bsky.social @ucsdhealth.bsky.social @themaximacenter.bsky.social @sickkidsto.bsky.social @childrensphila.bsky.social
@endocrinesociety.bsky.social @ucsdhealth.bsky.social @themaximacenter.bsky.social @sickkidsto.bsky.social @childrensphila.bsky.social
Setmelanotide Safe, Efficacious in Treating Acquired Hypothalamic Obesity
Setmelanotide was associated with significant weight reduction among patients aged 4 years and older with acquired hypothalamic obesity.
www.endocrinologyadvisor.com
July 14, 2025 at 7:03 PM
From #ENDO2025: #Setmelanotide was associated with significant #WeightReduction among adult and pediatric patients with acquired #HypothalamicObesity.
@endocrinesociety.bsky.social @ucsdhealth.bsky.social @themaximacenter.bsky.social @sickkidsto.bsky.social @childrensphila.bsky.social
@endocrinesociety.bsky.social @ucsdhealth.bsky.social @themaximacenter.bsky.social @sickkidsto.bsky.social @childrensphila.bsky.social
